Latest Hydrocodone Stories
FALLS CHURCH, Va., Nov.
WAYNE, Pa., Oct.
WAISMANN METHOD® Medical Director Recognizes Patient Trend and Suggests Strategies to Address Potential Dependency Issues ORANGE, Calif., Oct.
Pain Insights, Inc.
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
KemPharm's Intellectual Property Estate Now Includes Composition of Matter Patents for Two Ligand Activated Technology (LAT) Opioid Prodrugs - KP511 and KP201 CORALVILLE, Iowa, Sept.
KemPharm Joins CLADD in Support of Legislation from Health Canada to Encourage More Responsible Development and Administration of Prescription Opioids CORALVILLE, Iowa, Sept.
Studies to Investigate Ability of KP201 to Deter Abuse and Reduce Opioid-Induced Constipation CORALVILLE, Iowa, Sept.
STAMFORD, Conn., Sept.
- totally perplexed and mixed up.